Amtul R Carmichael

Prof. Amtul R Carmichael


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2023 in The Breast
Verified
Journal Article
Open access
AAA. Agrawal
A. Agrawal
LRL. Romics
L. Romics
DTDinesh Kumar Thekkinkattil
Dinesh Kumar Thekkinkattil
MSM. Soliman
M. Soliman
MKMonika Kaushik
Monika Kaushik
AHAhmed Hamad
Ahmed Hamad
Partial breast reconstruction with a pedicled chest wall perforator flap (CWPF) enables breast conservation in a higher tumour: breast volume ratio scenario. Since there is limited evidence, this retrospective cohort study aimed to ascertain immediate (30-days) and medium-term (follow-up duration) surgical outcomes. STROBE-compliant protocol ascertained CWPF outcomes between March 2011-March 2021. UK centres known to perform CWPF were invited to participate if they performed at least 10 cases. Data were retrospectively collected, including patient demographics, tumour and treatment characteristics, and surgical and oncological outcomes. Statistical analysis (R™) included multivariable logistic regression and sensitivity analysis. Across 15 centres, 507 patients with median age (54 years, IQR; 48-62), body mass index (25.4 kg/m2, IQR; 22.5-29), tumour size (26 mm, IQR; 18-35), and specimen weight (62 g, IQR; 40-92) had following flap types: LiCAP (54.1%, n = 273), MiCAP/AiCAP (19.6%, n = 99), LiCAP + LTAP (19.8%, n = 100) and TDAP (2.2%, n = 11). 30-days complication rates were in 12%: haematoma (4.3%, n = 22), wound infection (4.3%, n = 22), delayed wound healing (2.8%, n = 14) and flap loss (0.6%, n = 3; 1 full) leading to readmissions (2.6%, n = 13) and re-operations (2.6%, n = 13). Positive margins (n = 88, 17.7%) led to 15.9% (n = 79) re-excisions, including 7.5% (n = 37) at the planned 2nd of 2-stage surgery and 1.8% (n = 9) mastectomy. At median 23 months (IQR; 11-39) follow-up, there were 1.2% (n = 6) symmetrisations; recurrences: local (1%), regional/nodal (0.6%) and distant (3.2%). This large multicentre cohort study demonstrates acceptable complication and margin re-excision rates. CWPF extends the range of breast conservation techniques. Further studies are required for long-term oncological outcomes.

1 May 2021 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Verified
Journal Article
Closed access
ACAmtul R Carmichael
Amtul R Carmichael
AGA. Goyal
A. Goyal
ASA.S. Sami
A.S. Sami
ILI.M. Lahart
I.M. Lahart
KMK. Mokbel
K. Mokbel

27 March 2019
Verified
Book Chapter
Closed access
PDF file
ACAmtul R Carmichael
Amtul R Carmichael
KSKerstin Sandelin
Kerstin Sandelin

1 May 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
AHAlia Hussein
Alia Hussein
MRMariam Rizk
Mariam Rizk
Kefah MokbelKefah Mokbel
Kefah Mokbel
ACAmtul R Carmichael
Amtul R Carmichael
Background/Objectives: Artificial intelligence (AI) shows promise in supporting mammography interpretation and triaging referrals, potentially enhancing breast screening. However, successful AI integration depends on patient acceptance and trust. This study explores patient and public perceptions of AI in breast imaging and clinical decision-making to identify knowledge gaps and guide communication strategies. Methods: Paper surveys were distributed to women attending the Breast Care Unit at Queen’s Hospital, Burton, and the London Breast Institute between August and December 2025. Demographic data, levels of trust and comfort with AI, and concerns about AI were collected. Responses were analysed using descriptive statistics, Pearson’s Chi-square tests with Cramér’s V and thematic analysis. Results: One hundred and twenty participants completed the survey. Fifty percent would accept AI alongside clinicians for interpretation of mammograms or ultrasound scans, significantly associated with no previous breast cancer diagnosis (p = 0.02; Cramér’s V = 0.22, 2 degrees of freedom (df)) and technological comfort (p < 0.001; Cramér’s V = 0.42, 1 df). Lower acceptance was found among those with prior diagnosis and low comfort with technology. Acceptance of AI-assisted triage (44.5%) was also significantly associated with technological comfort (p = 0.008; Cramér’s V = 0.30, 1 df). Eighty percent reported no knowledge of AI use in breast clinics, and only 37% would trust AI findings. Qualitative analysis identified three themes: (1) clinician oversight as indispensable, (2) the knowledge gap as a barrier to acceptance, and (3) concerns about operational risks and accountability. Conclusions: Although patients were generally receptive to AI, acceptance was conditional on clinician supervision. Limited awareness and concerns about diagnostic accuracy remain barriers to implementation. Educational initiatives should precede widespread adoption to support informed and confident patient acceptance of AI-assisted imaging and decision-making.